Symbiont conversion
Symbiont conversion is a term that refers to the transformation of normally parasitic organisms into a symbiotic relationship with a host. It is the theory that microorganisms and cells that are often considered parasites can be "educated" and converted into symbionts, partners that live together for mutual benefit. A symbiosis is a living community in which two different species are closely related to each other and at least one species derives an advantage from the relationship. By contrast, parasitism signifies a relationship in which one organism (the parasite) lives at the expense of another (the host) without benefiting the latter. Symbiont conversion is the idea that an organism normally considered a parasite can be converted into a symbiotic relationship with a host through certain processes. This contrasts with traditional approaches that focus on eliminating or destroying pathogens. The theory suggests that instead of solely employing methods like chemotherapy or antibiotics (which can harm healthy cells), we can reprogram these organisms to become beneficial to the host.[1]
Theoretical basis: The symbiont conversion theory postulates that it is possible to influence parasites in such a way that they develop into symbionts and make a positive contribution to the host. This could be done, for example, by specifically modifying the genetic or physiological characteristics of the parasite or by creating an environment that favours the development of a symbiotic relationship.
Examples and applications: Although symbiont conversion is still a relatively new concept, there are already theoretical considerations and initial experimental approaches as to how this could be achieved. Possible applications could be in medicine, agriculture and environmental technology. For example, harmful bacteria could be converted into beneficial bacteria through symbiont conversion, which could be used to treat diseases or improve soil quality. In theory, symbiont conversion might also be a solution to antimicrobial resistance, as well as an alternative way to treat cancer. In essence, symbiont conversion theory offers a paradigm shift in how we approach disease treatment, suggesting that we can harness the power of symbiosis to create healthier interactions between organisms, rather than solely focusing on eradication.
Basically a literature survey shows that there are two different approaches towards the reprogramming of bacteria: On the one hand, bacteria can be reprogrammed by altering their genes, for example by using bacteriophages (viruses that target bacteria) or methods like CRISPR/Cas9. These approaches are usually conducted ex vivo. On the other hand, there is metabolic reprogramming: by adding certain substances to the bacteria, the behavior of the bacteria is modified. This can even be done in vivo. For true symbiont conversion, it seems an in vivo approach would be more desirable, as the objective is to “cure” living patients. However, this might perhaps be only possible by extracting bacteria from the human organism, modifying them ex vivo and then inserting them into the human organism again.
[2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18]
This article "Symbiont conversion" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Symbiont conversion. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
- ↑ https://www.researchgate.net/publication/368396626_Symbiont_Conversion_Theory
- ↑ Apura, Patrícia; Domingues, Susana; Viegas, Sandra C.; Arraiano, Cecília M. (2019). "Reprogramming bacteria with RNA regulators". Biochemical Society Transactions. 47 (5): 1279–1289. doi:10.1042/BST20190173. PMID 31642890.
- ↑ Bendriss, Ghizlane; MacDonald, Ross; McVeigh, Clare (2023). "Microbial Reprogramming in Obsessive–Compulsive Disorders: A Review of Gut–Brain Communication and Emerging Evidence". International Journal of Molecular Sciences. 24 (15): 11978. doi:10.3390/ijms241511978. PMC 10419219 Check
|pmc=value (help). PMID 37569349 Check|pmid=value (help). - ↑ Cheng, Yu-Yu; Chen, Zhengyi; Cao, Xinyun; Ross, Tyler D.; Falbel, Tanya G.; Burton, Briana M.; Venturelli, Ophelia S. (2023). "Programming bacteria for multiplexed DNA detection". Nature Communications. 14 (1): 2001. Bibcode:2023NatCo..14.2001C. doi:10.1038/s41467-023-37582-x. PMC 10086068 Check
|pmc=value (help). PMID 37037805 Check|pmid=value (help). - ↑ Chowdhury, Sreyan; Castro, Samuel; Coker, Courtney; Hinchliffe, Taylor E.; Arpaia, Nicholas; Danino, Tal (2019). "Programmable bacteria induce durable tumor regression and systemic antitumor immunity". Nature Medicine. 25 (7): 1057–1063. doi:10.1038/s41591-019-0498-z. PMC 6688650 Check
|pmc=value (help). PMID 31270504. - ↑ Cooper, Robert M.; Wright, Josephine A.; Ng, Jia Q.; Goyne, Jarrad M.; Suzuki, Nobumi; Lee, Young K.; Ichinose, Mari; Radford, Georgette; Ryan, Feargal J.; Kumar, Shalni; Thomas, Elaine M.; Vrbanac, Laura; Knight, Rob; Woods, Susan L.; Worthley, Daniel L.; Hasty, Jeff (2023). "Engineered bacteria detect tumor DNA". Science. 381 (6658): 682–686. Bibcode:2023Sci...381..682C. doi:10.1126/science.adf3974. PMC 10852993 Check
|pmc=value (help). PMID 37561843 Check|pmid=value (help). - ↑ Fredens, Julius; Wang, Kaihang; de la Torre, Daniel; Funke, Louise F. H.; Robertson, Wesley E.; Christova, Yonka; Chia, Tiongsun; Schmied, Wolfgang H.; Dunkelmann, Daniel L.; Beránek, Václav; Uttamapinant, Chayasith; Llamazares, Andres Gonzalez; Elliott, Thomas S.; Chin, Jason W. (2019). "Total synthesis of Escherichia coli with a recoded genome". Nature. 569 (7757): 514–518. Bibcode:2019Natur.569..514F. doi:10.1038/s41586-019-1192-5. PMC 7039709 Check
|pmc=value (help). PMID 31092918. - ↑ Fu, Shengwei; Zhang, Rongrong; Gao, Yanmei; Xiong, Jiarui; Li, Ye; Pu, Lu; Xia, Aiguo; Jin, Fan (2023). "Programming the lifestyles of engineered bacteria for cancer therapy". National Science Review. 10 (5): nwad031. doi:10.1093/nsr/nwad031. PMC 10089584 Check
|pmc=value (help). PMID 37056431 Check|pmid=value (help). - ↑ Gallivan, Justin P. (2007). "Toward reprogramming bacteria with small molecules and RNA". Current Opinion in Chemical Biology. 11 (6): 612–619. doi:10.1016/j.cbpa.2007.10.004. PMC 2169510. PMID 17967431.
- ↑ Gardlik, Roman; Wagnerova, Alexandra; Celec, Peter (2014). "Effects of bacteria-mediated reprogramming and antibiotic pretreatment on the course of colitis in mice". Molecular Medicine Reports. 10 (2): 983–988. doi:10.3892/mmr.2014.2244. PMID 24841084.
- ↑ Hsu, Bryan B.; Plant, Isaac N.; Lyon, Lorena; Anastassacos, Frances M.; Way, Jeffrey C.; Silver, Pamela A. (2020). "In situ reprogramming of gut bacteria by oral delivery". Nature Communications. 11 (1): 5030. Bibcode:2020NatCo..11.5030H. doi:10.1038/s41467-020-18614-2. PMC 7538559 Check
|pmc=value (help). PMID 33024097 Check|pmid=value (help). - ↑ https://www.researchgate.net/publication/328804805_Programming_Bacteria_With_Light-Sensors_and_Applications_in_Synthetic_Biology
- ↑ Meier, Stefanie S. M.; Multamäki, Elina; Ranzani, Américo T.; Takala, Heikki; Möglich, Andreas (2024). "Leveraging the histidine kinase-phosphatase duality to sculpt two-component signaling". Nature Communications. 15 (1): 4876. Bibcode:2024NatCo..15.4876M. doi:10.1038/s41467-024-49251-8. PMC 11164954 Check
|pmc=value (help). PMID 38858359 Check|pmid=value (help). - ↑ Navarro, Carla; Ortega, Ángel; Santeliz, Raquel; Garrido, Bermary; Chacín, Maricarmen; Galban, Néstor; Vera, Ivana; De Sanctis, Juan Bautista; Bermúdez, Valmore (2022). "Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches". Pharmaceutics. 14 (6): 1303. doi:10.3390/pharmaceutics14061303. PMC 9227908 Check
|pmc=value (help). PMID 35745875 Check|pmid=value (help). - ↑ Ngo, Hien Thi-Thu; Nguyen, Dinh-Huy; You, Sung-Hwan; Van Nguyen, Khuynh; Kim, So-Young; Hong, Yeongjin; Min, Jung-Joon (2024). "Reprogramming a Doxycycline-Inducible Gene Switch System for Bacteria-Mediated Cancer Therapy". Molecular Imaging and Biology. 26 (1): 148–161. doi:10.1007/s11307-023-01879-6. PMID 38017353 Check
|pmid=value (help). - ↑ Perera PGT; Linklater, D. P.; Vilagosh, Z.; Nguyen THP; Hanssen, E.; Rubanov, S.; Wanjara, S.; Aadum, B.; Alfred, R.; Dekiwadia, C.; Juodkazis, S.; Croft, R.; Ivanova, E. P. (2024). "Genetic Transformation of Plasmid DNA into Escherichia coli Using High Frequency Electromagnetic Energy". Nano Letters. 24 (4): 1145–1152. Bibcode:2024NanoL..24.1145P. doi:10.1021/acs.nanolett.3c03464. PMID 38194429 Check
|pmid=value (help). - ↑ Sieow, Brendan Fu-Long; Wun, Kwok Soon; Yong, Wei Peng; Hwang, In Young; Chang, Matthew Wook (2021). "Tweak to Treat: Reprograming Bacteria for Cancer Treatment". Trends in Cancer. 7 (5): 447–464. doi:10.1016/j.trecan.2020.11.004. PMID 33303401 Check
|pmid=value (help). - ↑ Xia, P. F.; Casini, I.; Schulz, S.; Klask, C. M.; Angenent, L. T.; Molitor, B. (2020). "Reprogramming Acetogenic Bacteria with CRISPR-Targeted Base Editing via Deamination". ACS Synthetic Biology. 9 (8): 2162–2171. doi:10.1021/acssynbio.0c00226. PMID 32610012 Check
|pmid=value (help).
